1. At a Glance – Blink and You’ll Miss the Drama
CreditAccess Grameen is that one microfinance stock which everyone respects, everyone owns at least once in life, and everyone complains about during bad cycles. Current market cap sits around ₹19,880 Cr, stock price hovering near ₹1,243, down in the last three months and politely reminding investors that microfinance is not a one-way escalator.
The company just reported Q3 FY26 results, clocking PAT of ₹252 Cr, quarterly revenue of ₹1,490 Cr, and AUM of ₹26,566 Cr. Asset quality remains the elephant in the room with GNPA at 3.99% and NNPA at 1.28%, while NIM stands tall at 12.5% like a bodybuilder refusing to diet.
Returns? ROE is currently 7.86%, ROCE 9.55%, which looks underwhelming if you ignore history and downright depressing if you don’t. Promoters still hold 66.3%, zero pledge, and institutions hover like strict parents. This quarter screamed recovery, not celebration.
2. Introduction – Welcome to the Microfinance Mahabharata
Microfinance is a simple business on paper: lend small amounts to many people, collect weekly, repeat forever. In reality, it behaves like Indian weather—mostly predictable, occasionally disastrous, and always blamed on external forces.
CreditAccess Grameen is the undisputed heavyweight here. With ~6% industry market share, 48.05 lakh active borrowers, and 2,059 branches across 16 states, this is not a side hustle—it’s a full-blown rural financial infrastructure.
But FY24 and early FY25 tested nerves. Delinquencies spiked, collections slowed, and analysts rediscovered words like “stress cycle” and “credit cost normalization.” Q3 FY26 is management saying, “Relax, we’re still alive, breathing, and collecting cash.”
This article reads
